| 摘要 |
FIELD: medicine. ^ SUBSTANCE: group of inventions relates to medicine, namely to pediatrics, and can be applied for treatment, prevention or reduction of systemic inflammatory in children at artificial feeding to level, which occurs at breast-feeding. For this purpose to child introduced is therapeutically efficient quantity of Lactobacillus rhamnosus GG (LGG) in combination with, at least, one long-chain polyunsaturated fatty acid (LCPUFA). ^ EFFECT: introduction of LGG and LCPUFA combination makes it possible to reduce systemic release of pro-inflammatory cytokines, chemokines and MPO considerably, conditioning efficiency of claimed therapy. ^ 14 cl, 7 ex, 7 dwg |
